Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells

Cell Growth and Differentiation

Volumn 8, Issue 2, 1997, Pages 133-143

  Scharnhorst, Volkher ^a   Kranenburg, Onno ^a,b   Van der Eb, Alex J ^a   Jochemsen, Aart G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; RETINOIC ACID; SOMATOMEDIN RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; EPITHELIUM CELL; ERYTHROLEUKEMIA CELL; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; NEPHROBLASTOMA; PRIORITY JOURNAL;

BLOTTING, WESTERN; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL LINE; DIMETHYL SULFOXIDE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, WILMS TUMOR; HUMANS; IMMEDIATE-EARLY PROTEINS; NEUROGLIA; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION FACTORS; TRETINOIN; WT1 PROTEINS;

EID: 0031033340     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Beckwith, J. B., Kiviat, N. B., and Bonadio, J. F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr. Pathol., 10: 1-36, 1990.
2. Reddy, J. C., and Licht J. D. The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochim. Biophys. Acta, 1287:1-28, 1996.
3. Pritchard-Jones, K., Flemming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., van Heyningen, V., and Hastie, N. The candidate Wilms' tumor gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
4. Buckler, A. J., Pelletier, J., Haber, D. A., Glaser, T., and Housman, D. E. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol. Cell. Bid., 11: 1707-1712, 1991.
5. Coppers, M. J., Campbell, C. E., and Williams, B. R. G. The role of WT1 in tumorigenesis. FASEB J., 7: 886-895, 1993.
6. Hastie, N. D. The genetics of Wilms' tumor - a case of disrupted development. Annu. Rev. Genet., 28: 523-558, 1994.
7. Kreidberg, J. A., Hannu, S., Loring, J. M., Maedra, M., Pelletier, J., Housman, D., and Jaenisch, R. WT-1 is required for early kidney development. Cell, 74: 679-691, 1993.
8. Phelan, S. A., Lindberg, C., and Call, K. M. Wilms' tumor gene, WT1, mRNA is downregulated during induction of erythroid and megakaryocytic differentiation ofK562 cells. Cell Growth & Differ., 5: 677-686, 1994.
9. Sekiya, M., Adachi, M., Hinoda, Y., Imai, K., and Yachi, A. Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Stood, 83: 1876-1882, 1994.
10. αi-2 protooncogene transcription. J. Biol. Chem., 269: 27503-27509, 1994.
11. αi-2 Protooncogene transcription. J. Biol. Chem., 271: 30760-30764, 1996.
12. McBurney, M. W., and Rogers, B. J. Isolation of male murine embryonal carcinoma cells and their chromosome replication patterns. Dev. Biol., 89: 503-508, 1982.
13. Evans, M. J., and Kaufmann, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature (Lond.), 292:154-156, 1981.
14. Martin, G. A. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 78: 7634-7638, 1981.
15. Doetschmann, T. C., Eistetter, H., Katz, M., Schmidt, W., and Kemler, R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol., 87: 27-45, 1985.
16. McBurney, M. W. P19 embryonal carcinoma cells. Int. J. Dev, Biol., 37: 135-140, 1993.
17. Jones-Villeneuve, E. M. V., McBurney, M. W., Rogers, A., and Kalnins, V. I. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol., 94: 253-262, 1982.
18. McBurney, M. W., Reuhl, K. R., Ally, A. I., Nasipuri, S., Bell, J. C., and Craig, J. Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J. Neurosci., 8: 1063-1073, 1988.
19. van der Kruijssen, C. M. M., van Achterberg, T. A. E., Hébert, J. M., de Waele, P., and van den Eijnden-van Raaij, A. J. M. Neuronal and mesodermal differentiation of P19 embryonal carcinoma cells is characterized by expression of specific marker genes and modulated by activin and fibroblast growth factors. Dev. Growth Differ., 37: 559-574, 1995.
20. McBurney, M. W., Jones-Villeneuve, E. M. V., Edwards, M. K. S., and Anderson, P. J. Control of muscle cell and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature (Lond.), 299:165-167, 1982.
21. Edwards, M. K. S., Harris, J. F., and McBurney, M. W. Induced muscle cell differentiation in an embryonal carcinoma cell fine. Mol. Cell. Biol., 3: 2280-2286, 1983.
22. Mummery, C. L., Feijen, A., van der Saag, P. T., van den Brink, C. E., and de Laat, S. W. Clonal variants of differentiated P19 embryonal carcinoma cells exhibit epidermal growth factor receptor kinase activity. Dev. Biol., 109: 402-410, 1985.
23. Mummery, C. L., Feijen, A., Moolenaar, W. H., van den Brink, C. E., - and de Laat, S. W. Establishment of a differentiated mesodermal line from P19 EC cells expressing functional PDGF and EGF receptors. Exp. Cell Res., 165: 229-242, 1986.
24. Gashler, A., and Sukhatme, V. P. Early growth response protein 1 (EGR-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol., 50: 191-224, 1995.
25. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA, 88: 9618-9622, 1991.
26. Morris, J. F., Madden, S. L., Tournay, A. E., Cook, D. M., Sukhatme, V. P., and Rauscher, F. J., III. Characterization of the zinc finger protein encoded by the Wilms' tumor locus. Oncogene, 6: 2339-2348, 1991.
27. Gashler, A. L., Bonthron, D. T., Madden, S. L., Rauscher, F. J-, III, Collins, T., and Sukhatme, V. P. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl. Acad. Sci. USA, 89: 10984-10988, 1992.
28. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., and Rauscher, F. J., III. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (Washington DC), 257: 674-678, 1992.
29. Dey, B. R., Sukhatme, V. P., Roberts, A. B., Sporn, M. B., Rauscher, F. J. III, and Kim, S-J. Repression of the transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol., 8: 595-602, 1994.
30. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., Rauscher, F. J., III, Sens, D. A., Garvin, A. J., LeRoith, D., and Roberts, C. T., Jr. Increased expression of the insulin-like growth factor I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc. Natl. Acad. Sci. USA, 90: 5828-5832, 1993.
31. Werner, H., Shen-Orr, Z., Rauscher, F. J., III, Morris, J. F., Roberts, C. T., Jr., and LeRoith, D. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol., 15: 3516-3522, 1995.
32. Englert, C., Hou, X., Kaheswaran, S., Bennett, P., Ngwu, C., Re, G. G., Garvin, A. J., Rosner, M. R., and Haber, D. A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J., 14: 4662-4675, 1995.
33. Ryan, G., Steele-Perkins, V., Morris, J. F., Rauscher, F. J., III, and Dressier, G. R. Repression of Pax-2 by WT1 during normal kidney development. Development (Camb.), 121: 867-875, 1995.
34. Madden, S. L., Cook, D. M., Morris, J. F., Gashler, A., Sukhatme, V. P., and Rauscher, F. J., III. Transeriptional repression mediated by the WT1 Wilims' tumor gene product. Science (Washington DC), 253: 1550-1553, 1991.
35. Larsson, S. H., Charlieu, J. P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., ROSS, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. Subnuclear localization of WT1 in splicing and transcription factor domains is regulated by alternative splicing. Cell, 81: 391-401, 1995.
36. Kennedy, D., Ramsdale, T., Mattick, J., and Little, M. An RNA recognition motif in Wilms' tumor protein (WT1) revealed by structural modelling. Nat Genet., 12: 329-332, 1996.
37. Rauscher, F. J., III, Mom's, J. F., Toumay, O. E., Cook, D. M., and Curran, T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
38. Menke, A. L., Riteco, N., van Ham, R. C. A., de Bruyne, C., Rauscher, F. J., III, van der Eb, A. J., and Jochemsen, A. G. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby rat kidney cells. Oncogene, 12: 537-546, 1996.
39. Nakagama, H., Heinrich, G., Pelletier, J., and Housman, D. E. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol. Cell. Biol., 15: 1489-1498, 1995.
40. Mummery, C. L., Feyen, A., Freund, E., and Shen, S. Characteristics of embryonic stem cell differentiation: a comparison with two embryonal carcinoma cell lines. Cell Differ. Dev., 30: 195-206, 1990.
41. Bruening, W., and Pelletier, J. A non AUG translational initiation event generates novel WT1 isoforms. J. Biol. Chem., 271: 8646-8654, 1996.
42. Solter, D., and Knowles, B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA, 75: 5565-5569, 1978.
43. Mundlos, S., Pelletier, J., Darveau, A., Bachmann, M., Winterpacht A., and Zabel, B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development (Camb.), 119: 1329-1341, 1993.
44. Darland, T., Samuels, M., Edwards, S. A., Sukhatme, V. P., and Adamson, E. D. Regulation of EGR-1 (Zfp-6) and c-fos expression in differentiating embryonal carcinoma cells. Oncogene, 6:1367-1376, 1991.
45. Joh, T., Darland, T., Samuels, M., Wu, J-X., and Adamson, E. D. Regulation of epidermal growth factor receptor gene expression in embryonal carcinoma cells. Cell Growth & Differ., 3: 315-325, 1992.
46. Armstrong, J. F., Pritchard-Jones, K., Bickmore, W. A., Hastie, N. D., and Bard, J. B. L. The expression of the Wilms' tumor gene, WT1, in the developing mammalian embryo. Mech. Dev., 40: 85-97, 1992.
47. Kent, J., Corriat, A-M., Sharpe, P. T., Hastie, N. D., and van Heyningen, V. The evolution of WT1 sequence and expression pattern in the vertebrates. Oncogene, 11: 1781-1792, 1995.
48. Sharma, M. P., Yang, X., Bowman, M., Roberts, V., and Sukumar, S. Molecular cloning of rat Wilms' tumor complementary DMA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res., 52: 6407-6412, 1992.
49. Rackley, R. R., Flenniken, A. M., Kuriyan, N. P., Kessler, P. M., Stoler, M. H., and Williams, B. R. G. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth & Differ., 4: 1023-1031, 1993.
50. Fraizer, G. C., Wu, Y-J., Hewitt, S. M., Maity, T., Ton, G. C. T., Huff, V., and Saunders, G. F. Transcriptional regulation of the human Wilms' tumor gene (WT1). J. Biol. Chem., 269: 8892-8900, 1994.
51. Rupprecht, H. D., Drummond, I.A., Madden, S. L., Rauscher, F. J., III, and Sukhatme, V. P. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J. Biol. Chem., 269: 6198-6206, 1994.
52. Wu, Y-J., Fraizer, G. C., and Saunders, G. F. GATA-1 transactivates the WT1 hematopoietic specific enhancer. J. Biol. Chem., 270: 5944-5949, 1995.
53. Mummery, C. L., van den Eijnden-van Raaij, A. J. M., Feijen, A., Freund, E., Hulskotte, E., Schoorlemmer, J., and Kruijer, W. Expression of growth factors during the differentiation of embryonic stem cells in monolayer. Dev. Biol., 142: 406-413, 1990.
54. Reddy, J. C., Hosono, S., and Licht, J. D. The transcriptional effect of WT1 is modulated by choice of expression vector. J. Biol. Chem., 270: 29976-29982, 1995.
55. Haber, D. A., Timmers, H. T. M., Pelletier, J., Sharp, P. A., and Housman, D. E. A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in the transformation of primary kidney cells. Proc. Natl. Acad. Sci. USA, 89: 6010-6014, 1992.
56. Algar, E. M., Khromykh, T., Smit, S. I., Blackburn, D. M., Bryson, G. J., and Smith, P. J. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukemia cell lines. Oncogene, 12: 1005-1014, 1996.
57. Muthukkumar, S., Nair, P., Sells, S. F., Maddiwar, N. G., Jacob, R. J., and Rangnekar, V. M. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol. Cell. Biol., 15: 6262-6272, 1995.
58. Brulet, P., Babinet, C., Kemler, R., and Jacob, F. Monoclonal antibodies against trophectoderm-specific markers during mouse biastocyst formation. Proc. Natl. Acad. Sci. USA, 77: 4113-4117, 1980.